Top Reads of September

The most downloaded content by health system pharmacy leaders in September 2025.

By McKesson Health Systems Editorial Team

Date

October 01, 2025

Read Time

2 minutes

Our most-downloaded content by health system teams in September includes a Q&A- style interview featuring one of our Professional & Advisory Services (P&AS) experts discussing the importance of monitoring ongoing changes in the 340B space, a downloadable checklist to help health systems prepare for modernizing their infusion strategy, and a simplified look at our Specialty Pharmacy Enablement expert’s three-pronged approach to success in specialty. Click on each of our recommended reads to learn more on Prescribed Perspectives about how partnering with McKesson can help your health system achieve more.

Podcast: Monitoring Ongoing 340B Changes and the Potential Impact for Health Systems

A person in a suit stands outside a glass building, using a smartphone with earphones on. A podcast-style interview discussing the importance of monitoring the changing 340B and IRA landscapes.

Listen now.

Checklist: 5 Questions to Ask When Evaluating Next Steps for Your Health System’s Infusion Strategy

A person in a suit interacts with a digital interface showing nine glowing checkboxes, all checked. Download this checklist for an at-a-glance view of important considerations when modernizing your health system’s infusion service line.

Read now.

A Successful Health System Pharmacy Strategy Starts with Access to These Three Things

Two people in lab coats work at a pharmacy counter with shelves of medications behind them. One of our Specialty Pharmacy Enablement (SPE) experts outlines her three-pronged approach for success and suggests the addition of a critical fourth.

Learn more.

Contact our experts today to learn more about partnering with McKesson to achieve more.

Subscribe Now

To learn how McKesson can help health systems achieve more, sign up to have the Prescribed Perspectives newsletter delivered directly to your inbox.

Brittany Ulrich, PharmD, CSP, BCBBS, examines how limited distribution drugs and payer requirements push specialty prescriptions outside the organization, eroding visibility into patient outcomes, and how Biologics by McKesson helps health systems expect more when it comes to maintaining care continuity.

Aerial view of a large warehouse complex with loading docks, trucks and intersecting roads.

Case Study: How McKesson’s Winter-Storm Playbook Kept Specialty Drugs Moving

Expect more for the business of pharmacy with a pressure-tested, multi-layered business continuity strategy.

Researcher in a laboratory looks through shelving lined with containers and supplies.

What You Should Know About the CMS Proposed 340B Payment Change

Dr. Andrew Wilson, B.S., Pharm.D., FASHP, reflects on the proposed CY 2027 OPPS rule for several outpatient drugs purchased through the 340B program, and the next phase of specialty drug margin management for the business of pharmacy.

Open laptop beside a stack of tabbed documents in a binder on a desk, with a softly blurred office background.

Top Prescribed Perspectives Reads for August

The top three Prescribed Perspectives articles most read by health systems in August.

Business professionals greet with a handshake in a modern office while colleagues stand nearby during a networking conversation.

Upcoming Event: inSPire 2026

Connect with McKesson at inSPire to help shape the future of specialty pharmacy

Top Reads of September

Podcast: Monitoring Ongoing 340B Changes and the Potential Impact for Health Systems

Checklist: 5 Questions to Ask When Evaluating Next Steps for Your Health System’s Infusion Strategy

A Successful Health System Pharmacy Strategy Starts with Access to These Three Things

Related Stories

Related Tags